Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Current Opinion in Virology
|
May 3, 2017
Letter to the Editor
Mamun Al-Mahtab, Michel Bazinet, Andrew Vaillant
Plos One
|
June 4, 2016
Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection
Mamun Al-Mahtab, Michel Bazinet, Andrew Vaillant
Hepatology Communications
|
July 17, 2023
Rapid monophasic HBsAg decline during nucleic-acid polymer-based therapy predicts functional cure
Leeor Hershkovich, Louis Shekhtman, Michel Bazinet, et al.
Journal of Viral Hepatitis
|
November 20, 2018
Variants of hepatitis B virus surface antigen observed during therapy with nucleic acid polymer REP 2139-Ca have no influence on treatment outcome and its detection by diagnostic assays
Hrvoje Mijočević, Hadi Karimzadeh, Judith Seebach, et al.
Antiviral Research
|
December 20, 2024
HBV serum RNA kinetics during nucleic acid polymers based therapy predict functional cure
Leeor Hershkovich, Scott J Cotler, Louis Shekhtman, et al.
Journal of Viral Hepatitis
|
July 20, 2019
Kinetics of hepatitis B surface antigen quasispecies during REP 2139-Ca therapy in HBeAg-positive chronic HBV infection
Zainab Usman, Hrvoje Mijočević, Hadi Karimzadeh, et al.
Urology
|
February 25, 2003
Cross-cultural validation of the UCLA prostate cancer index
Pierre I Karakiewicz, Michael W Kattan, Simon Tanguay, et al.
The Canadian Journal of Urology
|
June 1, 1996
Analysis of gland volume effect on the performance of PSA density in early detection of non-palpable, isoechoic prostate cancer
Pierre I. Karakiewicz, Michel Bazinet, Armen G. Aprikian, et al.
Gastroenterology
|
March 10, 2020
Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy
Michel Bazinet, Victor Pântea, Gheorghe Placinta, et al.
Journal of Viral Hepatitis
|
February 8, 2021
Benefit of transaminase elevations in establishing functional cure of HBV infection during nap-based combination therapy
Michel Bazinet, Victor Pântea, Gheorghe Placinta, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Current Opinion in Virology
|
May 3, 2017
Letter to the Editor
Mamun Al-Mahtab, Michel Bazinet, Andrew Vaillant
Plos One
|
June 4, 2016
Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection
Mamun Al-Mahtab, Michel Bazinet, Andrew Vaillant
Hepatology Communications
|
July 17, 2023
Rapid monophasic HBsAg decline during nucleic-acid polymer-based therapy predicts functional cure
Leeor Hershkovich, Louis Shekhtman, Michel Bazinet, et al.
Journal of Viral Hepatitis
|
November 20, 2018
Variants of hepatitis B virus surface antigen observed during therapy with nucleic acid polymer REP 2139-Ca have no influence on treatment outcome and its detection by diagnostic assays
Hrvoje Mijočević, Hadi Karimzadeh, Judith Seebach, et al.
Antiviral Research
|
December 20, 2024
HBV serum RNA kinetics during nucleic acid polymers based therapy predict functional cure
Leeor Hershkovich, Scott J Cotler, Louis Shekhtman, et al.
Journal of Viral Hepatitis
|
July 20, 2019
Kinetics of hepatitis B surface antigen quasispecies during REP 2139-Ca therapy in HBeAg-positive chronic HBV infection
Zainab Usman, Hrvoje Mijočević, Hadi Karimzadeh, et al.
Urology
|
February 25, 2003
Cross-cultural validation of the UCLA prostate cancer index
Pierre I Karakiewicz, Michael W Kattan, Simon Tanguay, et al.
The Canadian Journal of Urology
|
June 1, 1996
Analysis of gland volume effect on the performance of PSA density in early detection of non-palpable, isoechoic prostate cancer
Pierre I. Karakiewicz, Michel Bazinet, Armen G. Aprikian, et al.
Gastroenterology
|
March 10, 2020
Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy
Michel Bazinet, Victor Pântea, Gheorghe Placinta, et al.
Journal of Viral Hepatitis
|
February 8, 2021
Benefit of transaminase elevations in establishing functional cure of HBV infection during nap-based combination therapy
Michel Bazinet, Victor Pântea, Gheorghe Placinta, et al.
Page
of 2